Abcam Plc (ABC) Insider Buys £17,652.44 in Stock
Abcam Plc (LON:ABC) insider Louise Patten acquired 1,636 shares of the company’s stock in a transaction dated Thursday, September 14th. The stock was acquired at an average price of GBX 1,079 ($14.55) per share, with a total value of £17,652.44 ($23,799.97).
Shares of Abcam Plc (LON:ABC) opened at 1023.00 on Thursday. Abcam Plc has a 12 month low of GBX 759.50 and a 12 month high of GBX 1,113.00. The firm’s market cap is GBX 2.08 billion. The company’s 50 day moving average is GBX 1,056.46 and its 200-day moving average is GBX 959.01.
ABC has been the subject of a number of recent research reports. Numis Securities Ltd restated an “add” rating and issued a GBX 1,116 ($15.05) price objective on shares of Abcam Plc in a research note on Thursday, July 27th. Berenberg Bank restated a “buy” rating and issued a GBX 1,100 ($14.83) price objective on shares of Abcam Plc in a research note on Monday, September 11th. Peel Hunt restated a “hold” rating and issued a GBX 750 ($10.11) price objective on shares of Abcam Plc in a research note on Friday, August 18th. J P Morgan Chase & Co increased their price objective on shares of Abcam Plc from GBX 864 ($11.65) to GBX 946 ($12.75) and gave the company a “neutral” rating in a research note on Monday. Finally, Panmure Gordon restated a “sell” rating on shares of Abcam Plc in a research note on Monday, September 11th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of GBX 972.67 ($13.11).
Abcam Plc Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Stock Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related stocks with our FREE daily email newsletter.